MEDVi vs MyStart Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi and MyStart Health are tied at 7.7/10. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose MyStart Health for users who value a money-back weight-loss guarantee and price.

A side-by-side comparison of MEDVi and MyStart Health covering pricing, scores, medication types, insurance, and more to help you decide.

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

MyStart Health

#23 of 48

7.7/10

GLP-1 provider offering a unique money-back guarantee and price-lock protection for long-term cost certainty.

Visit MyStart Health

Feature	MEDVi	MyStart Health
Our Score	7.7/10	7.7/10
Starting Price	$299/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Users who value a money-back weight-loss guarantee and price-lock protection
Ranking	#22	#23

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

MyStart Health

Pros

+Price Lock Guarantee ensures your monthly rate never increases even as your GLP-1 dose escalates — a genuine differentiator
+Access to 600+ board-certified doctors with unlimited clinician messaging at no additional cost
+Competitive pricing at $149-$179/mo for compounded semaglutide with free shipping included
+HSA/FSA eligible — can use pre-tax health savings to pay for treatment

Cons

−Cash-pay only — no insurance accepted, which limits options for patients with GLP-1 coverage
−Only available in select states — not all 50, and the exact state list isn't published
−Compounded medications only — no brand-name GLP-1 options available

Our Verdict

MEDVi and MyStart Health are closely matched with identical scores of 7.7/10. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose MyStart Health if you want: users who value a money-back weight-loss guarantee and price-lock protection.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MEDVi nor MyStart Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review